The Future of Immunology: Tackling Blood Disorders and Cancer Together
The boundaries between immunology, haematology, and oncology are rapidly dissolving, and at the heart of this convergence lies a new frontier for patient care. At the upcoming ESID EHA SIOPE Focused Symposium 2025, taking place 18–20 November in Vienna, the spotlight will be on the critical interplay between immune dysfunction, blood disorders, and cancer.
Once considered rare, inborn errors of immunity (IEI) are now known to significantly impact the risk and progression of haematologic and oncologic diseases. As diagnoses become more complex and patient outcomes hinge on integrated strategies, immunologists are being called to the frontlines of multidisciplinary care. Furthermore, many haematological and oncological disorders are associated, very often due to therapies received, with acquired immunological disturbances.
The Hidden Connections: What the ESID Registry Reveals
New insights from the ESID Registry, which follows over 30,000 IEI patients, highlight how immune dysregulation is a strong predisposing factor for malignancies, especially blood cancers. These findings underscore the urgency for earlier diagnosis and proactive management of immune-related conditions like Severe Combined Immunodeficiency (SCID) and Familial Hemophagocytic Lymphohistiocytosis (FHL), both of which can lead to cytopenias, severe infections and even cancer, and be fatal if not treated properly.
These insights are reshaping how we think about immunity, not as a separate silo, but as a core pillar in the management of haematologic and oncologic diseases.
Why Immunologists Shouldn’t Miss ESID EHA SIOPE 2025
This symposium offers more than updates, it’s a platform for change. Here’s what you can expect:
- Multidisciplinary Collaboration
Learn from leading haematologists and oncologists how to align your expertise in immunology with their approaches, building a more holistic patient care pathway. - Deep Dive into Mechanisms & Therapies
Explore the genetic and immunological underpinnings of complex blood disorders and cancers and how these insights are informing emerging treatments. - Advance Your Practice
Gain actionable knowledge on screening, early diagnosis, and managing patients with overlapping conditions. Мissing an immunodeficiency can be life-altering. - Shape the Future of Care
Contribute to building new clinical guidelines, expand international research networks, and help define when and how to collaborate across fields.
Your Role in a Changing Landscape
Whether you’re a seasoned specialist or an early-career clinician, this is your opportunity to be part of a paradigm shift. The future of precision medicine demands cross-disciplinary fluency, and it starts with conversations like the ones we’ll be having in Vienna.
Together, ESID, EHA, and SIOPE invite you to join forces, exchange ideas, and co-create solutions that bridge immunology, haematology, and paediatric oncology. Let’s move beyond our silos and toward a future where every patient benefits from the full spectrum of our knowledge.
Be a Game Changer
Where: Vienna, Austria
When: 18–20 November 2025
Let’s unite science, passion, and expertise because tackling blood disorders and cancer begins with understanding immunity.
Key dates:
Clinical cases submission deadline: 22 April
Abstract submission deadline: 10 June